Search

everythinglearnresearchcommunity

for

Search:↓

Common noncancerous skin diseases have various treatments, including topical applications, light therapy, surgery, and medications, with psychological support being important.

Sleep problems and skin issues affect each other; poor sleep can worsen skin conditions, and some skin treatments can improve or harm sleep quality.

A 70-year-old woman with a rare skin condition improved after treatment with topical steroids and acitretin.

Adalimumab can cause complete hair loss in rare cases.

Tretinoin gel is safe for sun exposure, but tacalcitol doesn't significantly improve non-segmental vitiligo.

Skin lymphoproliferative disorders are hard to diagnose and often linked to systemic diseases, but most have a good prognosis with accurate diagnosis.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

Mice studies show that Protein Phosphatase 2A is crucial for cell growth, development, and disease prevention.

Mutations in Gasdermin A3 cause skin inflammation and hair loss by disrupting mitochondria.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

The document concludes that mouse models are crucial for studying hair biology and that all mutant mice may have hair growth abnormalities that require detailed analysis to identify.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

A woman's total hair loss from hepatitis C treatment grew back after stopping the medication.

Cell aging can be both good and bad for tissue repair.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Oral ciclosporin A and topical treatments both reduce hair loss and scaling in dogs with sebaceous adenitis, but using both together is most effective.

Mice can regenerate ear tissue without the p53 protein.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

Patients with oral lichen planus or oral lichenoid reactions had worse cholesterol levels and a higher risk of obesity compared to healthy individuals.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.